Maurizio Galderisi1, Patrizio Lancellotti2, Erwan Donal3, Nuno Cardim4, Thor Edvardsen5, Gilbert Habib6, Julien Magne2, Gerald Maurer7, Bogdan A Popescu8. 1. Department of Translational Medical Sciences, Federico II University Hospital, Naples, Italy mgalderi@unina.it. 2. Department of Cardiology, GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège Hospital, Belgium. 3. Department of Cardiology, Hospital Pontchaillou-University Medical Center, Rennes, France. 4. Cardiology Department, Hospital da Luz, Lisbon, Portugal. 5. Department of Cardiology, Oslo University Hospital, Norway. 6. Cardiology Department, Hospital La Timone, Marseille, France. 7. Division of Cardiology, Second Department of Medicine, Medical University of Vienna, Austria. 8. 'Carol Davila' University of Medicine and Pharmacy-Euroecolab, Institute of Cardiovascular Diseases, Bucharest, Romania.
Abstract
AIMS: The non-invasive estimation of left ventricular filling pressures (LVFPs) represents a main goal in the clinical setting. Current recommendations encourage the use of pulsed-wave Tissue Doppler for calculating the ratio between the preload-dependent transmitral E velocity and the average of septal and lateral early diastolic velocities (e') of the mitral annulus. Despite its wide use, real utility of the E/e' ratio has been recently challenged in patients with either very advanced heart failure or preserved left ventricular (LV) ejection fraction. However, only few studies performed the invasive and non-invasive estimation of LVFP simultaneously. The EURO-FILLING Study will validate the E/e' ratio (and additional non-invasive estimates) against simultaneously measured LVFP obtained by left heart catheterization in a multicentre study involving reference European echo laboratories collecting a wide population sample size of cardiac patients with and without heart failure. METHODS AND RESULTS: The EURO-FILLING study is a large, prospective observational study in which simultaneous assessment of invasive and non-invasive measurements of LVFP will be acquired in eight reference European centres. Centralized reading of the collected parameters will be performed in a core laboratory. Not only standardized echo Doppler measurements but also novel echo parameters such as LV global longitudinal strain and global atrial strain (obtainable by two-dimensional speckle tracking echocardiography) will be tested for predicting invasive measurements of LVFP. CONCLUSIONS: The EURO-FILLING study is expected to provide important information on non-invasive assessment of LVFP and to contribute to the standardization of this assessment in clinical practice. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The non-invasive estimation of left ventricular filling pressures (LVFPs) represents a main goal in the clinical setting. Current recommendations encourage the use of pulsed-wave Tissue Doppler for calculating the ratio between the preload-dependent transmitral E velocity and the average of septal and lateral early diastolic velocities (e') of the mitral annulus. Despite its wide use, real utility of the E/e' ratio has been recently challenged in patients with either very advanced heart failure or preserved left ventricular (LV) ejection fraction. However, only few studies performed the invasive and non-invasive estimation of LVFP simultaneously. The EURO-FILLING Study will validate the E/e' ratio (and additional non-invasive estimates) against simultaneously measured LVFP obtained by left heart catheterization in a multicentre study involving reference European echo laboratories collecting a wide population sample size of cardiac patients with and without heart failure. METHODS AND RESULTS: The EURO-FILLING study is a large, prospective observational study in which simultaneous assessment of invasive and non-invasive measurements of LVFP will be acquired in eight reference European centres. Centralized reading of the collected parameters will be performed in a core laboratory. Not only standardized echo Doppler measurements but also novel echo parameters such as LV global longitudinal strain and global atrial strain (obtainable by two-dimensional speckle tracking echocardiography) will be tested for predicting invasive measurements of LVFP. CONCLUSIONS: The EURO-FILLING study is expected to provide important information on non-invasive assessment of LVFP and to contribute to the standardization of this assessment in clinical practice. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Mário Santos; Jose Rivero; Shane D McCullough; Erin West; Alexander R Opotowsky; Aaron B Waxman; David M Systrom; Amil M Shah Journal: Circ Heart Fail Date: 2015-06-11 Impact factor: 8.790
Authors: Mihai Strachinaru; Bas M van Dalen; Nicolas Van Mieghem; Peter P T De Jaegere; Tjebbe W Galema; Marielle Morissens; Marcel L Geleijnse Journal: Cardiovasc Ultrasound Date: 2015-06-26 Impact factor: 2.062
Authors: Oleg F Sharifov; Chun G Schiros; Inmaculada Aban; Gilbert J Perry; Louis J Dell'italia; Steven G Lloyd; Thomas S Denney; Himanshu Gupta Journal: J Am Heart Assoc Date: 2017-12-29 Impact factor: 5.501
Authors: Oleg F Sharifov; Chun G Schiros; Inmaculada Aban; Thomas S Denney; Himanshu Gupta Journal: J Am Heart Assoc Date: 2016-01-25 Impact factor: 5.501